Type 2 Diabetes Trial, Recruiting NCT07262788 Sponsor: Steno Diabetes Center Copenhagen Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT07262788
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with type 2 diabetes (T2D) and are managing it with lifestyle changes and/or certain diabetes tablets (such as metformin, sulfonylureas, DPP-4 inhibitors, SGLT2 inhibitors, or incretin-based medications)
  • People whose blood sugar control (measured by a test called HbA1c) falls within a specific range — between 36 and 86 mmol/mol
  • People who have had type 2 diabetes for 6 years or less
  • People with a Body Mass Index (BMI) of 27 or higher (meaning they are overweight or obese by clinical measures)
  • People whose body weight has changed by no more than 3 kg over the past 3 months

Who may not be able to join:

  • People who have used insulin (any type) in the 6 months before screening
  • People with significant heart failure (where the heart pumps less than 40% of its capacity) who are currently taking or planning to take a medication from the SGLT-2 inhibitor group
  • People with heart disease — including a previous heart attack or stroke — for whom incretin-based therapy and/or an SGLT-2 inhibitor has been prescribed
  • People with kidney disease (based on specific kidney function and protein-in-urine test results lasting at least 3 months) who are currently taking or planning to take an SGLT-2 inhibitor
  • People with a physical health condition that would prevent them from taking part in the physical activity required during the trial
  • People with dietary restrictions or food allergies that would make it impossible to follow the trial's eating plan
  • People who would be unable to follow the trial's procedures and requirements
  • People with alcohol or drug misuse issues
  • People who are pregnant, planning a pregnancy, currently undergoing fertility treatment, or of reproductive age without using contraception
  • People with unstable mental health conditions that the trial team determines would make participation difficult
  • People who have been diagnosed with binge eating disorder
  • People who are currently taking part in, or planning to join, another clinical trial (including lifestyle or medication trials) for any health condition
  • People whose HbA1c is 60 mmol/mol or higher, who are taking 2 or more diabetes medications, and who also have certain specific blood test results suggesting a different type of diabetes may be present (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jonas Salling Quist Senior Researcher and Associate Professor, PhD, Steno Diabetes Center Copenhagen, University of Copenhagen - Department of Biomedical Sciences

Phone: +45 26176064

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Steno Diabetes Center Copenhagen
Registry
ClinicalTrials.gov
Start date
30 September 2025
Est. completion
1 March 2027

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Feasibility testing of diet adherence; Feasibility testing of exercise adherence; Feasibility testing of GP recruitment & safety procedures - quantitative assessment; Feasibility testing of GP experiences and study procedures - qualitative assessment; Feasibility testing of participant recruitment & retention; Feasibility testing of intervention participation - quantitative assessment; Feasibility testing of intervention participation - qualitative assessment; Feasibility testing of protocol adherence - number of days with deviations; Feasibility testing of acceptability and experiences

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov